Cargando…
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
Bronchiectasis is an increasing clinical problem, but multiple recent clinical trials have failed to reach their primary end-point. Difficulties in achieving “positive” bronchiectasis trials is reflected in a lack of agreement from trialists and regulators on what are the optimal end-points. To eval...
Autores principales: | Crichton, Megan L., Aliberti, Stefano, Chalmers, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488648/ https://www.ncbi.nlm.nih.gov/pubmed/30872400 http://dx.doi.org/10.1183/16000617.0108-2018 |
Ejemplares similares
-
Get together to increase awareness in bronchiectasis: a report of the 2(nd) World Bronchiectasis Conference
por: Aliberti, Stefano, et al.
Publicado: (2018) -
Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)
por: Artaraz, Amaia, et al.
Publicado: (2020) -
The Impact of the COVID-19 Pandemic on Exacerbations and Symptoms in Bronchiectasis: A Prospective Study
por: Crichton, Megan L., et al.
Publicado: (2021) -
Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial
por: Chalmers, James D., et al.
Publicado: (2019) -
“The missing ingredient”: the patient perspective of health related quality of life in bronchiectasis: a qualitative study
por: Dudgeon, Emily K., et al.
Publicado: (2018)